This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Uropharma Limited, Jotillou Enterprises Ltd., Synesis LLC. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Buckinghamshire, GB (2011)
- Aylesbury, GB (2019 - 2020)
Company Filing History:
3 out of 3 
1 out of 1 
1 out of 3 Years Active: 2011-2025
Title: Scott Glickman - Innovator in Medical Technology
Introduction
Scott Glickman, based in Aylesbury, GB, is a prolific inventor with a remarkable portfolio that includes four patents. His contributions to medical technology, particularly in the field of urinary tract health, have demonstrated his commitment to innovating solutions that enhance patient care and treatment efficiency.
Latest Patents
Glickman's latest patents showcase his innovative approaches to addressing urinary health issues. His patent for an **Intermittent Intravesical Therapeutic Administration System** details a unique intravesical intermittent instillation catheter. This catheter features a tube that houses both a urinary and an instillation lumen, equipped with drainage and instillation eyelets that allow seamless transition between draining urine and administering medicaments.
Additionally, one of his significant patents is for a **Medicinal Composition for Treating Urinary Tract Infection (UTI)**. This pharmaceutical composition is crafted to prevent or treat UTIs, chronic cystitis, overactive bladder, and bladder cancer, utilizing oligomeric tannins bound to anti-cancer agents. These innovations are instrumental in providing patients with targeted and effective treatment options.
Career Highlights
Scott Glickman has made notable advances in his field throughout his career. He has worked with companies like Uropharma Limited and Jotillou Enterprises Ltd., where he contributed his expertise in medical device development and pharmaceutical composition. His work has played a critical role in advancing treatment protocols and improving patient outcomes in urology.
Collaborations
Throughout his career, Glickman has collaborated with esteemed colleagues, including Howard Shapland and Christian Gerald Krueger. These partnerships have enhanced his research and development efforts, leading to innovative solutions and successful patent filings.
Conclusion
Scott Glickman exemplifies the spirit of innovation in the medical technology sector. Through his patents and collaborations, he has made significant contributions to addressing complex health challenges related to urinary tract conditions. His work continues to inspire future developments in medical devices and treatments, solidifying his role as a prominent inventor in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile